Attorney enrolled in breast cancer vaccine trial to speak at St. Andrew’s Oct. 18
Attorney enrolled in breast cancer vaccine trial to speak at St. Andrew’s Oct. 18 Mountain Home Observer
🎗️
Онкология
Рак молочной железы
411 материалов по теме, собраны автоматически из проверенных источников
Онкология
AstraZeneca's Phase 3 Trial of Combination Treatment for Breast Cancer Fails to Meet Primary Endpoint
AstraZeneca's Phase 3 Trial of Combination Treatment for Breast Cancer Fails to Meet Primary Endpoint marketscreener.com
Онкология
New analysis points to low overdiagnosis in breast cancer screening
When women take part in breast cancer screening, they are informed that screening may detect cancers that would never have caused symptoms or problems during their lifetime. This is known as overdiagnosis.
🎗️
Онкология
AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial
AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial FirstWord Pharma
Онкология
Wearable electric field therapy slows aggressive breast cancer, study finds
Wearable electric field therapy slows aggressive breast cancer, study finds The Brighter Side of News
🎗️
Онкология
AstraZeneca’s Etcamah flunks first-line breast cancer trial, adding to oral SERDs’ failure record
AstraZeneca’s Etcamah flunks first-line breast cancer trial, adding to oral SERDs’ failure record Fierce Pharma
Онкология
AI virtual cell uses protein dynamics to predict personalized breast cancer treatments
Not all cancer cells are the same, and neither are their responses to drugs. Finding the right drug for the right cancer cell is a long battle in drug development and in designing effective treatments. A new AI tool called ProteinTalks makes this task easier by accurately predicting whether a drug will be effective…
🎗️
Онкология
Advanced Breast Cancer Drug Fails Key Clinical Trial Days After Regulatory Approval
Advanced Breast Cancer Drug Fails Key Clinical Trial Days After Regulatory Approval ndtv.com
Онкология
Breast cancer pill from AstraZeneca misses mark in pivotal trial
Breast cancer pill from AstraZeneca misses mark in pivotal trial STAT
Онкология
SERENA-4 Phase III Trial Misses Primary PFS Endpoint for Camizestrant Plus Palbociclib in First-Line Advanced Breast Cancer
SERENA-4 Phase III Trial Misses Primary PFS Endpoint for Camizestrant Plus Palbociclib in First-Line Advanced Breast Cancer Oncodaily
🎗️
Онкология
AstraZeneca’s breast cancer drug fails in late-stage trial
AstraZeneca’s breast cancer drug fails in late-stage trial WTVB
Онкология
Breast Cancer Research Results: Challenges in Combining Focused Ultrasound with Immunotherapy | Newswise
Breast Cancer Research Results: Challenges in Combining Focused Ultrasound with Immunotherapy | Newswise Newswise
🎗️
Онкология
AstraZeneca's breast cancer pill fails in late-stage trial
AstraZeneca's breast cancer pill fails in late-stage trial reuters.com
🎗️
Онкология
AstraZeneca's Etcamah fails in late-stage trial as first-line breast cancer treatment
AstraZeneca's Etcamah fails in late-stage trial as first-line breast cancer treatment Seeking Alpha
🎗️
Онкология
AstraZeneca’s SERD Etcamah Fails in Phase III First-Line Breast Cancer Trial
AstraZeneca’s SERD Etcamah Fails in Phase III First-Line Breast Cancer Trial GenomeWeb